12 results
8-K
EX-99.1
CRBP
Corbus Pharmaceuticals Holdings Inc
5 Feb 24
Regulation FD Disclosure
8:12am
and in combination with semaglutide or tirzepatide *liver oil red stain Source(s): Company data on file. 48 vehicle CRB-913 (2.5 mg/kg) semaglutide (10 nmol/kg
8-K
EX-1.1
CRBP
Corbus Pharmaceuticals Holdings Inc
1 Feb 24
Corbus Pharmaceuticals Announces Proposed Public Offering
5:27pm
petroleum (including crude oil or any fraction thereof) and petroleum products, natural gas liquids, asbestos and asbestos containing materials
8-K
EX-99.2
CRBP
Corbus Pharmaceuticals Holdings Inc
26 Jan 24
Regulation FD Disclosure
7:47am
and in combination with semaglutide or tirzepatide *liver oil red stain Source(s): Company data on file. 47 vehicle CRB-913 (2.5 mg/kg) semaglutide (10
8-K
EX-99.1
CRBP
Corbus Pharmaceuticals Holdings Inc
14 Nov 23
Regulation FD Disclosure
5:19pm
oil red stain Source(s): Company data on file. 39 vehicle CRB-913 (2.5 mg/kg) semaglutide (10 nmol/kg) CRB-913 (2.5 mg/kg) + semaglutide (10 nmol/kg
8-K
EX-1.1
t82hf
7 Feb 20
Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:05pm
8-K
EX-1.1
2mka3hk20pnixx p2b
25 Jan 19
Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:01pm
D
l3vmbt6c649 89
23 Apr 14
$13M in equity / options, sold $6.31M, 45 investors
12:00am
D
994o5asjrcg
10 Jan 14
$90K in equity, sold $90K, 19 investors
12:00am
- Prev
- 1
- Next